CYP2A6/7/13 Polyclonal Antibody

CYP2A13 encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. Although its endogenous substrate has not been determined, it is known to metabolize 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a major nitrosamine specific to tobacco. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q.

Introducing the CYP2A6/7/13 Polyclonal Antibody, a cutting-edge scientific tool meticulously designed to facilitate accurate and reliable research in the field of cytochrome P450 enzymes. This high-quality antibody is specifically tailored to target the CYP2A6, CYP2A7, and CYP2A13 isoforms, enabling comprehensive investigation of their intricate roles and functions.

Crafted with utmost precision, this polyclonal antibody exhibits exceptional specificity and sensitivity, ensuring optimal detection and quantification of the CYP2A6, CYP2A7, and CYP2A13 proteins. Its robust performance guarantees precise and reproducible results, empowering researchers to delve deeper into the intricate mechanisms and pathways governed by these enzymes.

The CYP2A6/7/13 Polyclonal Antibody boasts an extensive range of applications, including but not limited to immunohistochemistry, western blotting, and enzyme-linked immunosorbent assays (ELISA). Its versatility allows for seamless integration into various experimental protocols, facilitating a comprehensive understanding of the expression patterns and localization of these cytochrome P450 enzymes.

With its exceptional quality and reliability, this polyclonal antibody is an indispensable asset for researchers seeking to unravel the complexities of CYP2A6, CYP2A7, and CYP2A13. Its meticulous design and rigorous validation ensure accurate and reproducible results, empowering scientists to advance their understanding of these crucial enzymes and their implications in various physiological and pathological processes.

Invest in the CYP2A6/7/13 Polyclonal Antibody today and unlock new frontiers in cytochrome P450 research. Experience the pinnacle of scientific excellence and elevate your investigations to unprecedented heights.